estrogen-receptor cancer

Clinical stage biotech company InventisBio closes $70m Series C financing
Pharmaceutical Business Review
Tue, 03/12/19 - 11:35 am
InventisBio
D-0502
estrogen-receptor cancer
Drug Combination Slows Growth of Most Common Type of Advanced Breast Cancer
Memorial Sloan Kettering Cancer Center
Sat, 06/2/18 - 10:55 pm
ASCO 2018
taselisib
fulvestrant
metastatic breast cancer
estrogen-receptor cancer